183 related articles for article (PubMed ID: 27699446)
21. Calreticulin mutation burden--is it a stable clone in patients with essential thrombocythemia and myelofibrosis?
Shuly Y; Nagar M; Ben-Asaf L; Kneller A; Steinberg DM; Amariglio N; Salomon O
Blood Cells Mol Dis; 2015 Dec; 55(4):281-3. PubMed ID: 26460248
[TBL] [Abstract][Full Text] [Related]
22. Driver mutations in primary myelofibrosis and their implications.
Szuber N; Tefferi A
Curr Opin Hematol; 2018 Mar; 25(2):129-135. PubMed ID: 29256926
[TBL] [Abstract][Full Text] [Related]
23. Somatic mutations of calreticulin in myeloproliferative neoplasms.
Klampfl T; Gisslinger H; Harutyunyan AS; Nivarthi H; Rumi E; Milosevic JD; Them NC; Berg T; Gisslinger B; Pietra D; Chen D; Vladimer GI; Bagienski K; Milanesi C; Casetti IC; Sant'Antonio E; Ferretti V; Elena C; Schischlik F; Cleary C; Six M; Schalling M; Schönegger A; Bock C; Malcovati L; Pascutto C; Superti-Furga G; Cazzola M; Kralovics R
N Engl J Med; 2013 Dec; 369(25):2379-90. PubMed ID: 24325356
[TBL] [Abstract][Full Text] [Related]
24. Unusual location of BCR-ABL1 fusion sequences in a chronic myeloid leukemia patient.
Zámečníkova A; Al Bahar S; Pandita R
Hematology; 2012 Nov; 17(6):321-4. PubMed ID: 22989955
[TBL] [Abstract][Full Text] [Related]
25. Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia.
Lee J; Kim DS; Lee HS; Choi SI; Cho YG
Ann Lab Med; 2017 Jan; 37(1):74-76. PubMed ID: 27834071
[No Abstract] [Full Text] [Related]
26. Chronic myeloid leukemia evolving after idiopathic myelofibrosis.
Bennett M; Chubar E
Isr Med Assoc J; 2007 Jul; 9(7):562-3. PubMed ID: 17710794
[No Abstract] [Full Text] [Related]
27. A novel, variant BCR-ABL1 transcript not detected by standard real-time quantitative PCR in a patient with chronic myeloid leukaemia.
McCarron SL; Haslam K; Kelly J; Duggan C; Langabeer SE
Int J Lab Hematol; 2012 Feb; 34(1):e1-2. PubMed ID: 21692997
[No Abstract] [Full Text] [Related]
28. Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis.
Bornhäuser M; Mohr B; Oelschlaegel U; Bornhäuser P; Jacki S; Ehninger G; Thiede C
Leukemia; 2007 Aug; 21(8):1824-6. PubMed ID: 17476275
[No Abstract] [Full Text] [Related]
29. A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia.
Jin C; Zhu X; Xiao M; Liu S; Liu X; Liu J; Xu X; Yi S; Meng L
Ann Lab Med; 2018 Mar; 38(2):169-171. PubMed ID: 29214763
[No Abstract] [Full Text] [Related]
30. Can absolute basophilia distinguish e1a2 BCR-ABL1 chronic myeloid leukemia from chronic myelomonocytic leukemia?
Langabeer SE; Bhreathnach Ú; Cahill MR; Elhassadi E; Ní Loingsigh S; Conneally E; Enright H
Blood Cells Mol Dis; 2021 Mar; 87():102521. PubMed ID: 33254033
[No Abstract] [Full Text] [Related]
31. Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia.
Soverini S; Branford S; Nicolini FE; Talpaz M; Deininger MW; Martinelli G; Müller MC; Radich JP; Shah NP
Leuk Res; 2014 Jan; 38(1):10-20. PubMed ID: 24131888
[TBL] [Abstract][Full Text] [Related]
32. Neutrophilic myelofibrosis presenting as Philadelphia chromosome negative BCR non-rearranged chronic myeloid leukemia.
Stewart K; Carstairs KC; Dubé ID; Keating A
Am J Hematol; 1990 May; 34(1):59-63. PubMed ID: 2327406
[TBL] [Abstract][Full Text] [Related]
33. Chronic myeloid leukemia, BCR-ABL1-positive, carrying NPM1 mutation - First case series from a single institution.
Young PE; Kanagal-Shamanna R; Hu S; Tang G; Thakral B; Daver N; Issa GC; Medeiros LJ; Konoplev S
Leuk Res; 2021 Dec; 111():106685. PubMed ID: 34438119
[No Abstract] [Full Text] [Related]
34. International reporting scale of BCR-ABL1 fusion transcript in chronic myeloid leukemia: first report from India.
Balasubramanian P; Chendamarai E; Markose P; Fletcher L; Branford S; George B; Mathews V; Chandy M; Srivastava A
Acta Haematol; 2012; 127(3):135-42. PubMed ID: 22249155
[TBL] [Abstract][Full Text] [Related]
35. Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy.
Quintás-Cardama A; Kantarjian H; Abruzzo LV; Cortes J
Leukemia; 2007 Nov; 21(11):2394-6. PubMed ID: 17690707
[No Abstract] [Full Text] [Related]
36. The incidence of co-existing BCR-ABL1 and JAK2 V617F rearrangements: implications for molecular diagnostics.
McCarron SL; Haslam K; Crampe M; Langabeer SE
Lab Hematol; 2012 Dec; 18(4):20-1. PubMed ID: 23253862
[No Abstract] [Full Text] [Related]
37. Novel BCR-ABL1 fusion identified by targeted next-generation sequencing in a patient with an atypical myeloproliferative neoplasm.
Frederick L; Beardell F; Viswanatha DS
Hum Pathol; 2014 Aug; 45(8):1784-9. PubMed ID: 24927924
[TBL] [Abstract][Full Text] [Related]
38. A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe Against Cancer Program.
Matsushita H; Yamamoto M; Tsuboi K; Masukawa A; Arakawa S; Asai S; Ogawa Y; Ando K; Miyachi H
Clin Chem Lab Med; 2009; 47(7):885-7. PubMed ID: 19575551
[No Abstract] [Full Text] [Related]
39. BCR-ABL mutations in chronic myeloid leukemia - not only detection.
Polakova KM; Zmekova V; Rulcova J; Klamova H; Zemanova Z; Moravcova J
Leuk Lymphoma; 2008 Aug; 49(8):1620-2. PubMed ID: 18452092
[No Abstract] [Full Text] [Related]
40. Prospective analysis of low-level BCR-ABL1 T315I mutation in CD34 + cells of patients with de novo chronic myeloid leukemia.
Jurcek T; Razga F; Mazancova P; Musilova M; Dvorakova D; Borsky M; Zackova D; Dobesova B; Semerad L; Mayer J; Racil Z
Leuk Lymphoma; 2014 Aug; 55(8):1915-7. PubMed ID: 24304421
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
